{"disease":{"id":"end-stage-renal-disease-with-renal-transplant","name":"end stage renal disease with renal transplant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07053462","title":"CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}